Propanc Biopharma (PPCB) Notes Payables (2013 - 2025)
Propanc Biopharma (PPCB) posted quarterly Notes Payables of $543312.0 for Q2 2025, up 165.43% year-over-year from $204694.0 in Q2 2024, and up 93.0% quarter-over-quarter from $281508.0 in Q1 2025.
Propanc Biopharma (PPCB) Notes Payables (2013 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Notes Payables for 11 consecutive years, with $543312.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Notes Payables rose 165.43% year-over-year to $543312.0; the TTM figure through Jun 2025 stood at $543312.0 (up 165.43% YoY), while the FY2025 annual figure was $543312.0, up 165.43% from the prior year.
- Notes Payables climbed to $543312.0 in Q2 2025 per PPCB's latest filing, from $281508.0 in the prior quarter.
- Across five years, Notes Payables topped out at $543312.0 in Q2 2025 and bottomed at $72404.0 in Q4 2022.
- Historically, Notes Payables has averaged $208138.2 across 4 years, with a median of $168217.0 in 2024.
- Annual changes were most pronounced in 2024 — Notes Payables rose 27.44% — and 2025, when it soared 165.43%.
- Propanc Biopharma's Notes Payables stood at $72404.0 in 2022, then jumped by 82.31% to $132000.0 in 2023, then rose by 27.44% to $168217.0 in 2024, then soared by 222.98% to $543312.0 in 2025.
- Business Quant data shows PPCB's Notes Payables at $543312.0 in Q2 2025, $281508.0 in Q1 2025, and $168217.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 543,312.00 |
| Mar 31, 2025 | 281,508.00 |
| Dec 31, 2024 | 168,217.00 |
| Sep 30, 2024 | 213,109.00 |
| Jun 30, 2024 | 204,694.00 |
| Mar 31, 2024 | 132,000.00 |
| Dec 31, 2023 | 132,000.00 |
| Sep 30, 2023 | 126,000.00 |
| Dec 31, 2022 | 72,404.00 |
| Mar 31, 2020 | 1.01 Mn |
| Dec 31, 2019 | 826,853.00 |
| Jun 30, 2019 | 917,337.00 |
| Dec 31, 2017 | 143.00 |
| Sep 30, 2017 | 142.00 |
| Jun 30, 2017 | 3,769.00 |
| Mar 31, 2017 | 16,200.00 |
| Dec 31, 2016 | 19,543.00 |
| Sep 30, 2016 | 36,934.00 |
| Jun 30, 2016 | 119,690.00 |
| Mar 31, 2016 | 80,630.00 |